{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:22:26Z","timestamp":1782310946960,"version":"3.54.5"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002787","name":"Department of National Defence and the Canadian Armed Forces","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA206025"],"award-info":[{"award-number":["R01CA206025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["BC171929"],"award-info":[{"award-number":["BC171929"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR190108"],"award-info":[{"award-number":["RR190108"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bone.2021.116245","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T01:35:28Z","timestamp":1635384928000},"page":"116245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Systemic effects of abnormal bone resorption on muscle, metabolism, and cognition"],"prefix":"10.1016","volume":"154","author":[{"given":"Trupti","family":"Trivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A.","family":"Guise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"Suppl 3","key":"10.1016\/j.bone.2021.116245_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1185\/03007995.2010.533162","article-title":"Understanding and optimizing bone health in breast cancer","volume":"26","author":"Guise","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bone.2021.116245_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115570","article-title":"Bisphosphonates and breast cancer - from cautious palliation to saving lives","volume":"140","author":"Coleman","year":"2020","journal-title":"Bone"},{"issue":"9757","key":"10.1016\/j.bone.2021.116245_bb0020","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0140-6736(10)62051-X","article-title":"First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC myeloma IX): a randomised controlled trial","volume":"376","author":"Morgan","year":"2010","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.bone.2021.116245_bb0025","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2021.116245_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115566","article-title":"Bisphosphonates and lifespan","volume":"141","author":"Center","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116245_bb0035","doi-asserted-by":"crossref","first-page":"115390","DOI":"10.1016\/j.bone.2020.115390","article-title":"Zoledronate","volume":"137","author":"Reid","year":"2020","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jbo.2013.12.001","article-title":"The anti-tumour effects of zoledronic acid","volume":"3","author":"Zekri","year":"2014","journal-title":"J. Bone Oncol."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bone.2010.07.016","article-title":"Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class","volume":"48","author":"Clezardin","year":"2011","journal-title":"Bone"},{"issue":"15","key":"10.1016\/j.bone.2021.116245_bb0050","doi-asserted-by":"crossref","first-page":"19835","DOI":"10.18632\/aging.203395","article-title":"Bisphosphonates and breast cancer survival: a meta-analysis and trial sequential analysis of 81508 participants from 23 prospective epidemiological studies","volume":"13","author":"Liu","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"1\u20132","key":"10.1016\/j.bone.2021.116245_bb0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0303-7207(01)00496-8","article-title":"Involvement of activin in the regulation of bone metabolism","volume":"180","author":"Sakai","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0060","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jbm.a.31085","article-title":"Quantification of various growth factors in different demineralized bone matrix preparations","volume":"81","author":"Wildemann","year":"2007","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"8","key":"10.1016\/j.bone.2021.116245_bb0065","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0070","first-page":"18","article-title":"Cancer and bone","volume":"19","author":"Guise","year":"1998","journal-title":"Endocr. Rev."},{"issue":"1\u20132","key":"10.1016\/j.bone.2021.116245_bb0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mce.2009.07.004","article-title":"The critical role of the bone microenvironment in cancer metastases","volume":"310","author":"Casimiro","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"issue":"9","key":"10.1016\/j.bone.2021.116245_bb0080","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/jbmr.2231","article-title":"Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways","volume":"29","author":"Zheng","year":"2014","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.bone.2021.116245_bb0085","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nm.1943","article-title":"Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis","volume":"15","author":"Korpal","year":"2009","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","article-title":"TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development","volume":"103","author":"Yin","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2021.116245_bb0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00003086-199001000-00036","article-title":"Role of transforming growth factor-beta in bone remodeling","volume":"250","author":"Bonewald","year":"1990","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"24","key":"10.1016\/j.bone.2021.116245_bb0100","doi-asserted-by":"crossref","first-page":"21352","DOI":"10.1074\/jbc.M111663200","article-title":"Proteolysis of latent transforming growth factor-beta (TGF-beta )-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix","volume":"277","author":"Dallas","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"52","key":"10.1016\/j.bone.2021.116245_bb0105","doi-asserted-by":"crossref","first-page":"18813","DOI":"10.1073\/pnas.0507417102","article-title":"TGF-beta regulates the mechanical properties and composition of bone matrix","volume":"102","author":"Balooch","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bone.2010.08.004","article-title":"TGF-beta in cancer and bone: implications for treatment of bone metastases","volume":"48","author":"Juarez","year":"2011","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2021.116245_bb0115","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.bone.2021.116245_bb0120","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminoncol.2010.10.007","article-title":"Examining the metastatic niche: targeting the microenvironment","volume":"37","author":"Guise","year":"2010","journal-title":"Semin. Oncol."},{"issue":"5","key":"10.1016\/j.bone.2021.116245_bb0125","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1042\/BST20200717","article-title":"Extracellular vesicles and the extracellular matrix: a new paradigm or old news?","volume":"48","author":"Lewin","year":"2020","journal-title":"Biochem. Soc. Trans."},{"issue":"6","key":"10.1016\/j.bone.2021.116245_bb0130","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/aba446","article-title":"Emerging local delivery strategies to enhance bone regeneration","volume":"15","author":"Elangovan","year":"2020","journal-title":"Biomed. Mater."},{"issue":"10","key":"10.1016\/j.bone.2021.116245_bb0135","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2174\/187152009789735008","article-title":"Agents targeting prostate cancer bone metastasis","volume":"9","author":"Mohammad","year":"2009","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"Suppl(2)","key":"10.1016\/j.bone.2021.116245_bb0140","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.3816\/CBC.2005.s.004","article-title":"Molecular mechanisms of breast cancer metastases to bone","volume":"5","author":"Guise","year":"2005","journal-title":"Clin. Breast Cancer"},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/pcan.2011.7","article-title":"Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US medicare beneficiaries, 1999\u20132006","volume":"14","author":"Sathiakumar","year":"2011","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"5","key":"10.1016\/j.bone.2021.116245_bb0150","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.cell.2013.08.020","article-title":"Breast cancer bone metastases: it's all about the neighborhood","volume":"154","author":"Guise","year":"2013","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bone.2021.116245_bb0155","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-07-0234","article-title":"Molecular biology of bone metastasis","volume":"6","author":"Kingsley","year":"2007","journal-title":"Mol. Cancer Ther."},{"issue":"11","key":"10.1016\/j.bone.2021.116245_bb0160","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1080\/14712598.2020.1814731","article-title":"Denosumab for cancer-related bone loss","volume":"20","author":"Dell'Aquila","year":"2020","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"4","key":"10.1016\/j.bone.2021.116245_bb0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3747\/co.27.6631","article-title":"Practical update for the use of bone-targeted agents in patients with bone metastases from metastatic breast cancer or castration-resistant prostate cancer","volume":"27","author":"Southcott","year":"2020","journal-title":"Curr. Oncol."},{"issue":"8","key":"10.1016\/j.bone.2021.116245_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082034","article-title":"Impact of extraskeletal metastases on skeletal-related events in metastatic castration-resistant prostate cancer with bone metastases","volume":"12","author":"Lobo-Martins","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bone.2021.116245_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111335","article-title":"Aging, obese-insulin resistance, and bone remodeling","volume":"191","author":"Imerb","year":"2020","journal-title":"Mech. Ageing Dev."},{"issue":"16","key":"10.1016\/j.bone.2021.116245_bb0180","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.18632\/oncotarget.15803","article-title":"The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm","volume":"8","author":"Trivedi","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bone.2021.116245_bb0185","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bone.2010.07.012","article-title":"Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis","volume":"47","author":"Ooi","year":"2010","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2021.116245_bb0190","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.18632\/oncotarget.14139","article-title":"Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo","volume":"8","author":"Wright","year":"2017","journal-title":"Oncotarget"},{"issue":"Suppl. 2","key":"10.1016\/j.bone.2021.116245_bb0195","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1007\/s00586-003-0603-2","article-title":"Overview of osteoporosis: pathophysiology and determinants of bone strength","volume":"12","author":"Bono","year":"2003","journal-title":"Eur. Spine J."},{"issue":"6","key":"10.1016\/j.bone.2021.116245_bb0200","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/13697137.2020.1767567","article-title":"Factors of mineral homeostasis impairment and bone mineral density loss in women with central hypogonadism","volume":"23","author":"Ilovayskaya","year":"2020","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0205","first-page":"1286","article-title":"Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on muscle and bone health","volume":"25","author":"Bargiota","year":"2020","journal-title":"J. BUON"},{"key":"10.1016\/j.bone.2021.116245_bb0210","doi-asserted-by":"crossref","first-page":"4602129","DOI":"10.1155\/2017\/4602129","article-title":"Male hypogonadism and osteoporosis: the effects, clinical consequences, and treatment of testosterone deficiency in bone health","volume":"2017","author":"Golds","year":"2017","journal-title":"Int. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.bone.2021.116245_bb0215","first-page":"479","article-title":"Bone loss in primary hyperparathyroidism","volume":"109","author":"Gryfe","year":"1973","journal-title":"Can. Med. Assoc. J."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0220","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.surg.2019.04.059","article-title":"Skeletal effects of combined medical and surgical management of primary hyperparathyroidism","volume":"167","author":"Orr","year":"2020","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.bone.2021.116245_bb0225","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5694\/mja2.50280","article-title":"Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: position statement summary","volume":"211","author":"Grossmann","year":"2019","journal-title":"Med. J. Aust."},{"issue":"10","key":"10.1016\/j.bone.2021.116245_bb0230","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1634\/theoncologist.11-10-1121","article-title":"Bone loss and fracture risk associated with cancer therapy","volume":"11","author":"Guise","year":"2006","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0235","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jbmr.1749","article-title":"Effects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy Series","volume":"28","author":"Morrissey","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0240","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i1.20","article-title":"Cancer treatment-related bone disease","volume":"19","author":"Brown","year":"2009","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0245","doi-asserted-by":"crossref","first-page":"11933","DOI":"10.1038\/s41598-020-68890-7","article-title":"Estrogens decrease osteoclast number by attenuating mitochondria oxidative phosphorylation and ATP production in early osteoclast precursors","volume":"10","author":"Kim","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bone.2021.116245_bb0250","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41413-020-0102-7","article-title":"Aging and menopause reprogram osteoclast precursors for aggressive bone resorption","volume":"8","author":"Moller","year":"2020","journal-title":"Bone Res."},{"issue":"Suppl","key":"10.1016\/j.bone.2021.116245_bb0255","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/0378-5122(96)01015-8","article-title":"Estrogen and bone metabolism","volume":"23","author":"Vaananen","year":"1996","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0260","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/bcr2818","article-title":"Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management","volume":"13","author":"Gaillard","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.bone.2021.116245_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061529","article-title":"Pathophysiology of bone loss in patients with prostate cancer receiving androgen-deprivation therapy and lifestyle modifications for the management of bone health: a comprehensive review","volume":"12","author":"Kim","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bone.2021.116245_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07357907.2020.1855353","article-title":"Chemo\/radiotherapy-induced bone marrow niche alterations","author":"Rafieemehr","year":"2020","journal-title":"Cancer Investig."},{"issue":"7","key":"10.1016\/j.bone.2021.116245_bb0275","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/jbmr.2458","article-title":"Single-limb irradiation induces local and systemic bone loss in a murine model","volume":"30","author":"Wright","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0280","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1158\/1078-0432.CCR-10-1595","article-title":"Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer","volume":"17","author":"Edwards","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bone.2021.116245_bb0285","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.beem.2018.05.005","article-title":"Paget's disease of bone","volume":"32","author":"Appelman-Dijkstra","year":"2018","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0290","doi-asserted-by":"crossref","first-page":"85","DOI":"10.11005\/jbm.2014.21.2.85","article-title":"Pathobiology of Paget's disease of bone","volume":"21","author":"Galson","year":"2014","journal-title":"J. Bone Metab."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0295","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jbmr.3886","article-title":"Increased fracture risk in women treated with aromatase inhibitors versus tamoxifen: beneficial effect of bisphosphonates","volume":"35","author":"Pineda-Moncusi","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116245_bb0300","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bone.2018.09.010","article-title":"Bone health evaluation one year after aromatase inhibitors completion","volume":"117","author":"Pineda-Moncusi","year":"2018","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2021.116245_bb0305","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/nur.21608","article-title":"Effects of a three-month therapeutic lifestyle modification program to improve bone health in postmenopausal korean women in a rural community: a randomized controlled trial","volume":"37","author":"Oh","year":"2014","journal-title":"Res. Nurs. Health"},{"issue":"8","key":"10.1016\/j.bone.2021.116245_bb0310","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ctrv.2010.04.003","article-title":"Metastasis and bone loss: advancing treatment and prevention","volume":"36","author":"Coleman","year":"2010","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.bone.2021.116245_bb0315","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1055\/s-0035-1546151","article-title":"Bone-targeted therapy","volume":"75","author":"Salmen","year":"2015","journal-title":"Geburtshilfe Frauenheilkd."},{"issue":"9","key":"10.1016\/j.bone.2021.116245_bb0320","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0325","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00774-019-01052-6","article-title":"Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma","volume":"38","author":"Jeon","year":"2020","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bone.2021.116245_bb0330","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejca.2018.02.004","article-title":"Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01\/04) study","volume":"94","author":"Wilson","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bone.2021.116245_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbo.2017.03.001","article-title":"Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG","volume":"7","author":"Hadji","year":"2017","journal-title":"J. Bone Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2021.116245_bb0340","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ctrv.2008.03.006","article-title":"Antitumor effects of bisphosphonates: promising preclinical evidence","volume":"34","author":"Guise","year":"2008","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0345","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/tbj.13730","article-title":"Adjuvant bisphosphonate therapy in early-stage breast cancer-treating the soil to kill the seed","volume":"26","author":"Brufsky","year":"2020","journal-title":"Breast J."},{"issue":"12","key":"10.1016\/j.bone.2021.116245_bb0350","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1158\/0008-5472.CAN-05-0264","article-title":"Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity","volume":"65","author":"Clezardin","year":"2005","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0355","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1210\/clinem\/dgaa756","article-title":"Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS","volume":"106","author":"Tsourdi","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.bone.2021.116245_bb0360","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41585-019-0251-x","article-title":"Radium-223 mechanism of action: implications for use in treatment combinations","volume":"16","author":"Morris","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.bone.2021.116245_bb0365","doi-asserted-by":"crossref","DOI":"10.23736\/S0393-2249.20.03808-4","article-title":"Radium-223 in mCPRC patients: a large real-life Italian multicenter study","author":"Frantellizzi","year":"2020","journal-title":"Minerva Urol. Nefrol."},{"issue":"34","key":"10.1016\/j.bone.2021.116245_bb0370","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021506","article-title":"Vitamin D supplement on prevention of fall and fracture: a meta-analysis of randomized controlled trials","volume":"99","author":"Thanapluetiwong","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bone.2021.116245_bb0375","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.biopha.2017.09.018","article-title":"1,25(OH)2D3 deficiency increases TM40D tumor growth in bone and accelerates tumor-induced bone destruction in a breast cancer bone metastasis model","volume":"95","author":"Lu","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.bone.2021.116245_bb0380","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/iju.13170","article-title":"Skeletal complications in cancer patients with bone metastases","volume":"23","author":"Tsuzuki","year":"2016","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.bone.2021.116245_bb0385","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bone.2015.02.010","article-title":"Bone and muscle: interactions beyond mechanical","volume":"80","author":"Brotto","year":"2015","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2021.116245_bb0390","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/jbmr.3037","article-title":"Association of muscle weakness with post-fracture mortality in older men and women: a 25-year prospective study","volume":"32","author":"Pham","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.bone.2021.116245_bb0395","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/gerona\/61.10.1059","article-title":"The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study","volume":"61","author":"Goodpaster","year":"2006","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0400","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10549-014-2986-7","article-title":"A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI","volume":"146","author":"Lintermans","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0405","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10549-018-4924-6","article-title":"Impact of primary breast cancer therapy on energetic capacity and body composition","volume":"172","author":"Ballinger","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"issue":"9","key":"10.1016\/j.bone.2021.116245_bb0410","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0959-8049(00)00084-8","article-title":"Fatigue in patients with prostate cancer receiving hormone therapy","volume":"36","author":"Stone","year":"2000","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0415","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.urolonc.2006.12.014","article-title":"Androgen deprivation therapy for prostate cancer: effects on hand function","volume":"26","author":"Soyupek","year":"2008","journal-title":"Urol. Oncol."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0420","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/pcan.2008.51","article-title":"Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation","volume":"12","author":"Galvao","year":"2009","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"5","key":"10.1016\/j.bone.2021.116245_bb0425","doi-asserted-by":"crossref","first-page":"R371","DOI":"10.1530\/ERC-14-0172","article-title":"Muscle and bone effects of androgen deprivation therapy: current and emerging therapies","volume":"21","author":"Cheung","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"issue":"5","key":"10.1016\/j.bone.2021.116245_bb0430","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","article-title":"Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer","volume":"14","author":"Bines","year":"1996","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0435","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s10549-010-0899-7","article-title":"Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?","volume":"123","author":"Cameron","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0440","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/mi.7.3.6","article-title":"Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues","volume":"7","author":"Chen","year":"2007","journal-title":"Mol. Interv."},{"issue":"28","key":"10.1016\/j.bone.2021.116245_bb0445","doi-asserted-by":"crossref","first-page":"43442","DOI":"10.18632\/oncotarget.9779","article-title":"Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1\/2 and p38 MAPKs","volume":"7","author":"Barreto","year":"2016","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.bone.2021.116245_bb0450","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1089\/ars.2011.3965","article-title":"Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress","volume":"15","author":"Gilliam","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"12","key":"10.1016\/j.bone.2021.116245_bb0455","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1210\/jc.2003-030604","article-title":"Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the longitudinal aging study Amsterdam","volume":"88","author":"Visser","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bone.2021.116245_bb0460","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s002230010085","article-title":"Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement","volume":"66","author":"Glerup","year":"2000","journal-title":"Calcif. Tissue Int."},{"issue":"4","key":"10.1016\/j.bone.2021.116245_bb0465","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11764-014-0378-y","article-title":"Physical activity and fitness in women with metastatic breast cancer","volume":"8","author":"Yee","year":"2014","journal-title":"J. Cancer Surviv."},{"issue":"11","key":"10.1016\/j.bone.2021.116245_bb0470","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nm.3961","article-title":"Excess TGF-beta mediates muscle weakness associated with bone metastases in mice","volume":"21","author":"Waning","year":"2015","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0475","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.22232","article-title":"Transforming growth factor-beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin-1 and scleraxis","volume":"45","author":"Mendias","year":"2012","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.bone.2021.116245_bb0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005275","article-title":"Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone","volume":"4","author":"Mohammad","year":"2009","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bone.2021.116245_bb0485","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027090","article-title":"Anti-transforming growth factor ss antibody treatment rescues bone loss and prevents breast cancer metastasis to bone","volume":"6","author":"Biswas","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2021.116245_bb0490","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/bonekey.2015.59","article-title":"Cancer-associated muscle weakness: what's bone got to do with it?","volume":"4","author":"Waning","year":"2015","journal-title":"Bonekey Rep."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0495","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11914-017-0344-5","article-title":"The role of TGFbeta in bone-muscle crosstalk","volume":"15","author":"Regan","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"issue":"4","key":"10.1016\/j.bone.2021.116245_bb0500","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1096\/fj.13-245894","article-title":"Elevated expression of activins promotes muscle wasting and cachexia","volume":"28","author":"Chen","year":"2014","journal-title":"FASEB J."},{"issue":"23","key":"10.1016\/j.bone.2021.116245_bb0505","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1158\/0008-5472.CAN-12-1444","article-title":"Halofuginone inhibits the establishment and progression of melanoma bone metastases","volume":"72","author":"Juarez","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2021.116245_bb0510","first-page":"5","article-title":"Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness","author":"Hesse","year":"2019","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.bone.2021.116245_bb0515","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/jbmr.2869","article-title":"Protection from glucocorticoid-induced osteoporosis by anti-catabolic signaling in the absence of Sost\/Sclerostin","volume":"31","author":"Sato","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0520","first-page":"664","article-title":"Glucocorticoids induce bone and muscle atrophy by tissue-specific mechanisms upstream of E3 ubiquitin ligases","volume":"158","author":"Sato","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2021.116245_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115194","article-title":"Burn injury and restoration of muscle function","volume":"132","author":"Klein","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.bone.2021.116245_bb0530","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fendo.2019.00543","article-title":"Molecular mechanisms responsible for the rescue effects of pamidronate on muscle atrophy in pediatric burn patients","volume":"10","author":"Pin","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0535","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jbmr.3890","article-title":"Zoledronic acid improves muscle function in healthy mice treated with chemotherapy","volume":"35","author":"Hain","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.116245_bb0540","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fendo.2019.00809","article-title":"Bisphosphonate treatment ameliorates chemotherapy-induced bone and muscle abnormalities in young mice","volume":"10","author":"Essex","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bone.2021.116245_bb0545","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bone.2014.10.011","article-title":"Periostin expression contributes to cortical bone loss during unloading","volume":"71","author":"Gerbaix","year":"2015","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0550","first-page":"111","article-title":"Sarcopenia and fragility fractures","volume":"49","author":"Cederholm","year":"2013","journal-title":"Eur. J. Phys. Rehabil. Med."},{"issue":"1\u20132","key":"10.1016\/j.bone.2021.116245_bb0555","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00335-015-9611-x","article-title":"Modulation of unloading-induced bone loss in mice with altered ERK signaling","volume":"27","author":"Sankaran","year":"2016","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.bone.2021.116245_bb0560","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0021-9258(18)60342-4","article-title":"Aerobic metabolism of glucose by bone","volume":"237","author":"Cohn","year":"1962","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.bone.2021.116245_bb0565","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.2174\/13816128113196660690","article-title":"Interaction between bone and muscle in older persons with mobility limitations","volume":"20","author":"Ferrucci","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0570","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1210\/en.2002-220072","article-title":"Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation","volume":"144","author":"Lu","year":"2003","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.bone.2021.116245_bb0575","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.2337\/diabetes.54.10.2875","article-title":"Bone formation is impaired in a model of type 1 diabetes","volume":"54","author":"Thrailkill","year":"2005","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.bone.2021.116245_bb0580","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4158\/EP12141.RA","article-title":"Bone as an endocrine organ","volume":"18","author":"Guntur","year":"2012","journal-title":"Endocr. Pract."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0585","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1139\/o05-163","article-title":"Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages","volume":"84","author":"Gopalakrishnan","year":"2006","journal-title":"Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.bone.2021.116245_bb0590","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.molmet.2013.08.004","article-title":"In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice","volume":"2","author":"Lacombe","year":"2013","journal-title":"Mol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2021.116245_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI72323","article-title":"Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation","volume":"124","author":"Wei","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.bone.2021.116245_bb0600","doi-asserted-by":"crossref","DOI":"10.3390\/nu10070847","article-title":"Undercarboxylated osteocalcin: experimental and human evidence for a role in glucose homeostasis and muscle regulation of insulin sensitivity","volume":"10","author":"Lin","year":"2018","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0605","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bone.2021.116245_bb0610","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3389\/fendo.2019.00798","article-title":"Association of serum total osteocalcin concentrations with endogenous glucocorticoids and insulin sensitivity markers in 12-year-old children: a cross-sectional study","volume":"10","author":"Seppa","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bone.2021.116245_bb0615","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/842598","article-title":"The relationship between serum osteocalcin concentration and glucose metabolism in patients with type 2 diabetes mellitus","volume":"2013","author":"Wang","year":"2013","journal-title":"Int. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0620","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2008-1422","article-title":"Association between serum osteocalcin and markers of metabolic phenotype","volume":"94","author":"Pittas","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bone.2021.116245_bb0625","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1359\/jbmr.081234","article-title":"Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly swedish men","volume":"24","author":"Kindblom","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0630","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023918","article-title":"Relationship between serum osteocalcin\/undercarboxylated osteocalcin and type 2 diabetes: a systematic review\/meta-analysis study protocol","volume":"9","author":"Liu","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0635","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-10-0414","article-title":"Reduced serum total osteocalcin is associated with metabolic syndrome in older men via waist circumference, hyperglycemia, and triglyceride levels","volume":"163","author":"Yeap","year":"2010","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0640","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molmet.2014.12.010","article-title":"NPY signalling in early osteoblasts controls glucose homeostasis","volume":"4","author":"Lee","year":"2015","journal-title":"Mol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0645","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00223-016-0210-y","article-title":"Bone-derived factors: a new gateway to regulate glycemia","volume":"100","author":"Bonnet","year":"2017","journal-title":"Calcif. Tissue Int."},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0650","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/en.2014-1637","article-title":"Periostin induces pancreatic regeneration","volume":"156","author":"Smid","year":"2015","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0655","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ajpath.2015.09.022","article-title":"Loss of periostin results in impaired regeneration and pancreatic atrophy after cerulein-induced pancreatitis","volume":"186","author":"Hausmann","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0660","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1042\/CS20160543","article-title":"Decreased circulating BMP-9 levels in patients with type 2 diabetes is a signature of insulin resistance","volume":"131","author":"Luo","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0665","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nm.3084","article-title":"Blockade of receptor activator of nuclear factor-kappaB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus","volume":"19","author":"Kiechl","year":"2013","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.bone.2021.116245_bb0670","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1172\/JCI125915","article-title":"RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass","volume":"129","author":"Bonnet","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"20","key":"10.1016\/j.bone.2021.116245_bb0675","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1200\/JCO.2017.76.3524","article-title":"Diabetes after hormone therapy in breast cancer survivors: a case-cohort study","volume":"36","author":"Hamood","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0680","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ncpuro1296","article-title":"Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion","volume":"6","author":"Harris","year":"2009","journal-title":"Nat. Clin. Pract. Urol."},{"issue":"12","key":"10.1016\/j.bone.2021.116245_bb0685","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0690","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2217\/fon.14.145","article-title":"Metastatic castration-resistant prostate cancer: time for innovation","volume":"11","author":"Tucci","year":"2015","journal-title":"Future Oncol."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0695","doi-asserted-by":"crossref","first-page":"115","DOI":"10.14310\/horm.2002.1727","article-title":"Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications","volume":"16","author":"Tzortzis","year":"2017","journal-title":"Hormones (Athens)"},{"issue":"4","key":"10.1016\/j.bone.2021.116245_bb0700","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.prnil.2016.07.005","article-title":"Studying the effect of type 2 diabetes mellitus on prostate-related parameters: a prospective single institutional study","volume":"4","author":"Elabbady","year":"2016","journal-title":"Prostate Int."},{"issue":"4","key":"10.1016\/j.bone.2021.116245_bb0705","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tem.2013.12.006","article-title":"Glucocorticoids and bone: local effects and systemic implications","volume":"25","author":"Henneicke","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2021.116245_bb0710","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00223-011-9515-z","article-title":"Risk of newly diagnosed type 2 diabetes is reduced in users of alendronate","volume":"89","author":"Vestergaard","year":"2011","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"10.1016\/j.bone.2021.116245_bb0715","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1210\/jc.2014-3481","article-title":"Bisphosphonates and glucose homeostasis: a population-based, retrospective cohort study","volume":"100","author":"Toulis","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.116245_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154264","article-title":"Extra-skeletal effects of bisphosphonates","volume":"110","author":"Panagiotakou","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.bone.2021.116245_bb0725","doi-asserted-by":"crossref","first-page":"1809150","DOI":"10.1155\/2020\/1809150","article-title":"Effect of denosumab on glucose homeostasis in postmenopausal women with breast cancer treated with aromatase inhibitors: a pilot study","volume":"2020","author":"Rossini","year":"2020","journal-title":"Int. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0730","first-page":"55","article-title":"Growth hormone and bone","volume":"19","author":"Ohlsson","year":"1998","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0735","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1748-1716.1986.tb07843.x","article-title":"Vagally induced non-adrenergic, non-cholinergic contractions in the feline small intestine\u2013an involvement of opioid receptors?","volume":"126","author":"Gustafsson","year":"1986","journal-title":"Acta Physiol. Scand."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0740","first-page":"85","article-title":"Pituitary-bone connection in skeletal regulation","volume":"28","author":"Zaidi","year":"2016","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"issue":"26","key":"10.1016\/j.bone.2021.116245_bb0745","doi-asserted-by":"crossref","first-page":"19092","DOI":"10.1074\/jbc.M700644200","article-title":"Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis","volume":"282","author":"Baldock","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bone.2021.116245_bb0750","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0755","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","article-title":"Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass","volume":"100","author":"Ducy","year":"2000","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bone.2021.116245_bb0760","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bone.2012.02.639","article-title":"Effect of co-morbidities on fracture risk: findings from the global longitudinal study of osteoporosis in women (GLOW)","volume":"50","author":"Dennison","year":"2012","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0765","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/smi.2806","article-title":"Post-traumatic stress disorder and risk of osteoporosis: a nationwide longitudinal study","volume":"34","author":"Huang","year":"2018","journal-title":"Stress. Health"},{"issue":"5","key":"10.1016\/j.bone.2021.116245_bb0770","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051533","article-title":"Impact of bone fracture on ischemic stroke recovery","volume":"19","author":"Wei","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0775","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ageing\/afq146","article-title":"Hip fracture risk and subsequent mortality among Alzheimer's disease patients in the United Kingdom, 1988\u20132007","volume":"40","author":"Baker","year":"2011","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0780","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2310\/JIM.0b013e3182761264","article-title":"The value of osteopontin in the assessment of bone mineral density status in postmenopausal women","volume":"61","author":"Fodor","year":"2013","journal-title":"J. Investig. Med."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0785","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1210\/clinem\/dgaa864","article-title":"Osteoporosis and the risk of Parkinson\u2019s disease: a nationwide propensity score-matched longitudinal follow-up study","volume":"106","author":"Feng","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2021.116245_bb0790","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/jbmr.1814","article-title":"Partial reductions in mechanical loading yield proportional changes in bone density, bone architecture, and muscle mass","volume":"28","author":"Ellman","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0795","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1034\/j.1601-5215.2002.51007.x","article-title":"Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures","volume":"51","author":"Lui","year":"2003","journal-title":"J. Am. Geriatr. Soc."},{"issue":"10","key":"10.1016\/j.bone.2021.116245_bb0800","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1532-5415.1999.tb05196.x","article-title":"Association between bone mineral density and cognitive decline in older women","volume":"47","author":"Yaffe","year":"1999","journal-title":"J. Am. Geriatr. Soc."},{"issue":"41","key":"10.1016\/j.bone.2021.116245_bb0805","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012755","article-title":"Bone mineral loss and cognitive impairment: the PRESENT project","volume":"97","author":"Kang","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"1\u20132","key":"10.1016\/j.bone.2021.116245_bb0810","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jnr.23827","article-title":"Sex and the development of Alzheimer's disease","volume":"95","author":"Pike","year":"2017","journal-title":"J. Neurosci. Res."},{"issue":"12","key":"10.1016\/j.bone.2021.116245_bb0815","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/j.psyneuen.2013.08.005","article-title":"Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer's risk in a cohort of british women","volume":"38","author":"Fox","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0820","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cell.2013.08.042","article-title":"Maternal and offspring pools of osteocalcin influence brain development and functions","volume":"155","author":"Oury","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0825","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11154-015-9312-5","article-title":"Bone, brain & beyond","volume":"16","author":"Chamouni","year":"2015","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.bone.2021.116245_bb0830","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fnmol.2018.00343","article-title":"Osteocalcin ameliorates motor dysfunction in a 6-hydroxydopamine-induced Parkinson's disease rat model through AKT\/GSK3beta signaling","volume":"11","author":"Guo","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bone.2021.116245_bb0835","first-page":"81","article-title":"Mutational dysostosis (cleidocranial dysostosis)","volume":"28","author":"Soule","year":"1946","journal-title":"J. Bone Joint Surg. Am."},{"issue":"3","key":"10.1016\/j.bone.2021.116245_bb0840","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/humu.10043","article-title":"Mutations in the RUNX2 gene in patients with cleidocranial dysplasia","volume":"19","author":"Otto","year":"2002","journal-title":"Hum. Mutat."},{"issue":"12","key":"10.1016\/j.bone.2021.116245_bb0845","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.molmet.2017.10.001","article-title":"Modulation of cognition and anxiety-like behavior by bone remodeling","volume":"6","author":"Khrimian","year":"2017","journal-title":"Mol. Metab."},{"issue":"8","key":"10.1016\/j.bone.2021.116245_bb0850","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/33.8.2410480","article-title":"A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections","volume":"33","author":"Lopez-De Leon","year":"1985","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bone.2021.116245_bb0855","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3389\/fphys.2018.00667","article-title":"The effects of moderate physical exercise on adult cognition: a systematic review","volume":"9","author":"Fernandes","year":"2018","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0860","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ageing\/afr138","article-title":"Is there a role for physical activity in preventing cognitive decline in people with mild cognitive impairment?","volume":"41","author":"Barber","year":"2012","journal-title":"Age Ageing"},{"key":"10.1016\/j.bone.2021.116245_bb0865","doi-asserted-by":"crossref","first-page":"4840531","DOI":"10.1155\/2018\/4840531","article-title":"The effectiveness of physical exercise on bone density in osteoporotic patients","volume":"2018","author":"Benedetti","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0870","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/oby.21729","article-title":"The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors","volume":"25","author":"Thomas","year":"2017","journal-title":"Obesity (Silver Spring)"},{"issue":"7645","key":"10.1016\/j.bone.2021.116245_bb0875","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature21697","article-title":"MC4R-dependent suppression of appetite by bone-derived lipocalin 2","volume":"543","author":"Mosialou","year":"2017","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bone.2021.116245_bb0880","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1634\/theoncologist.2008-0130","article-title":"Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy","volume":"13","author":"Dietrich","year":"2008","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0885","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00491918","article-title":"Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents","volume":"144","author":"Lou","year":"1985","journal-title":"Eur. J. Pediatr."},{"issue":"2","key":"10.1016\/j.bone.2021.116245_bb0890","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.2002.20.2.485","article-title":"Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma","volume":"20","author":"Ahles","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bone.2021.116245_bb0895","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1139\/apnm-2013-0380","article-title":"Relationship between exercise behavior, cardiorespiratory fitness, and cognitive function in early breast cancer patients treated with doxorubicin-containing chemotherapy: a pilot study","volume":"39","author":"Crowgey","year":"2014","journal-title":"Appl. Physiol. Nutr. Metab."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0900","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/02841860802314738","article-title":"Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study","volume":"48","author":"Schilder","year":"2009","journal-title":"Acta Oncol."},{"issue":"5","key":"10.1016\/j.bone.2021.116245_bb0905","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/cam4.2069","article-title":"Cognitive complaints in cancer survivors and expectations for support: results from a web-based survey","volume":"8","author":"Lange","year":"2019","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0910","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/pon.709","article-title":"Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study","volume":"13","author":"Jenkins","year":"2004","journal-title":"Psychooncology"},{"issue":"8","key":"10.1016\/j.bone.2021.116245_bb0915","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1586\/era.11.112","article-title":"Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors","volume":"11","author":"Batalo","year":"2011","journal-title":"Expert. Rev. Anticancer. Ther."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0920","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/bcr2806","article-title":"Do aromatase inhibitors have adverse effects on cognitive function?","volume":"13","author":"Phillips","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"8","key":"10.1016\/j.bone.2021.116245_bb0925","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/pon.5442","article-title":"The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients","volume":"29","author":"Holtfrerich","year":"2020","journal-title":"Psychooncology"},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0930","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/WAD.0000000000000415","article-title":"Androgen deprivation therapy use and risk of mild cognitive impairment in prostate cancer patients","volume":"35","author":"Alonso-Quinones","year":"2020","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0935","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00223-020-00684-5","article-title":"Are bisphosphonates associated with adverse metabolic and cognitive Effects? A study in intact rats and rats fed high-fat high-fructose diet","volume":"107","author":"Gancheva","year":"2020","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2021.116245_bb0940","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pbb.2014.12.006","article-title":"Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model","volume":"129","author":"Citraro","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0945","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/1871530316666160330105952","article-title":"Effects of bisphosphonates and calcium plus vitamin-D supplements on cognitive function in postmenopausal osteoporosis section sign","volume":"16","author":"Safer","year":"2016","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"10.1016\/j.bone.2021.116245_bb0950","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1871530315666151104115829","article-title":"Zoledronic acid use and risk of cognitive decline among elderly women and men with osteoporosis","volume":"16","author":"Tasci","year":"2016","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.bone.2021.116245_bb0955","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/1735-1995.193503","article-title":"The effects of zoledronic acid treatment on depression and quality of life in women with postmenopausal osteoporosis: a clinical trial study","volume":"21","author":"Gokosmanoglu","year":"2016","journal-title":"J. Res. Med. Sci."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221004117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221004117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:46:38Z","timestamp":1762659998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221004117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":191,"alternative-id":["S8756328221004117"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116245","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic effects of abnormal bone resorption on muscle, metabolism, and cognition","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116245","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116245"}}